PATENT CLAIM ANALYSIS

Application Number: 15748691
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2019-01
Patent Classification: ["514", "449000"]

Abstract:
The present invention provides a pharmaceutical composition for oral administration, comprising (a) 4 to 40% by weight of a taxane, (b) 10 to 30% by weight of a medium chain triglyceride, (c) 30 to 70% by weight of monooleoyl glycerol, (d) 5 to 30% by weight of a surfactant, and (e) 10 to 30% by weight of polyoxyl glyceryl fatty acid ester and a process for preparing the same.

Claim (Index 3):
The pharmaceutical composition for oral administration according to  claim 2 , wherein the polyoxyl glyceryl fatty acid ester is one or more selected from the group consisting of caprylocaproyl polyoxyl-32 glyceride, lauroyl polyoxyl-32 glyceride, and stearoyl polyoxyl-32 glyceride.

Metadata:
- Claim Count in Document: 19.0
- Percentile: 86.0
- Lexical Diversity: 1.91489
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['15523021', '09281430', '15454898', '14690289', '10047902']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8511743108004954
- 35 USC 102 Novelty (BERT): 0.5607723500425946
- Combined Prediction Score: 0.8221341147247053
- Mean Citation Score: 314.50464
- Max Citation Score: 477.9424
- Similarity Product: 351.14825258636483

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test